HONG KONG MERIDIAN E-COMMERCE CO.,LIMITED – Trademark Portfolio

Entity Type: 99

HONG KONG MERIDIAN E-COMMERCE CO.,LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include DR MERIT. The owner is based in SAN PO KONG.

ROOM D07 8TH FLOOR, PHASE II, KAI TAK

FACTORY BUILDING, 99 KING FUK STREET,

SAN PO KONG , HK

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DR MERIT
DR MERIT
Registered 2025

Trademark Classifications

HONG KONG MERIDIAN E-COMMERCE CO.,LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does HONG KONG MERIDIAN E-COMMERCE CO.,LIMITED have?

HONG KONG MERIDIAN E-COMMERCE CO.,LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does HONG KONG MERIDIAN E-COMMERCE CO.,LIMITED file in?

HONG KONG MERIDIAN E-COMMERCE CO.,LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are HONG KONG MERIDIAN E-COMMERCE CO.,LIMITED's most well-known trademarks?

HONG KONG MERIDIAN E-COMMERCE CO.,LIMITED's registered trademark portfolio includes well-known marks such as DR MERIT. These are among 1 currently registered trademark in the portfolio.

What is HONG KONG MERIDIAN E-COMMERCE CO.,LIMITED's trademark registration success rate?

HONG KONG MERIDIAN E-COMMERCE CO.,LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.